SCHEMBL9824993

SCHEMBL9824993

COc1ccc(/C=C/c2ccccc2)c(CC(C)NCCc2c(Cl)cccc2Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP1B1 Q16678 2/20 0.44
SLC2A1 P11166 1/20 0.43
RELA Q04206 3/20 0.42
NFE2L2 Q16236 1/20 0.42
CASR P41180 3/20 0.40
SIGMAR1 Q99720 2/20 0.39
HTR1A P08908 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
SLC6A2 P23975 1/20 0.39
HRH2 P25021 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HRH1 P35367 1/20 0.39
OPRM1 P35372 1/20 0.39
DRD3 P35462 1/20 0.39
OPRK1 P41145 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9824303 1.00 CYP1A1 (0.44) CYP1A1CYP1A2CYP1B1SLC2A1RELA
SCHEMBL9825013 1.00 CYP1A1 (0.44) CYP1A1CYP1A2CYP1B1SLC2A1RELA
SCHEMBL9824218 0.86 SLC2A1 (0.48) CYP1A1CYP1A2CYP1B1SLC2A1RELA
SCHEMBL9824522 0.86 SLC2A1 (0.48) CYP1A1CYP1A2CYP1B1SLC2A1RELA
SCHEMBL9824627 0.85 SLC2A1 (0.50) CYP1A1CYP1A2CYP1B1SLC2A1SIGMAR1
SCHEMBL9824526 0.85 SLC2A1 (0.50) CYP1A1CYP1A2CYP1B1SLC2A1SIGMAR1
SCHEMBL9824898 0.85 SLC2A1 (0.50) CYP1A1CYP1A2CYP1B1SLC2A1SIGMAR1
SCHEMBL9824503 0.81 SLC2A1 (0.49) CYP1A1CYP1A2CYP1B1SLC2A1SIGMAR1
SCHEMBL9824630 0.81 SLC2A1 (0.49) CYP1A1CYP1A2CYP1B1SLC2A1SIGMAR1
SCHEMBL10759050 0.81 SLC2A1 (0.49) CYP1A1CYP1A2CYP1B1SLC2A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0250254-A1 Cis & trans stilbenes and their composition for the treatment of hypertension McNeilab, Inc. (US) 1987-12-23 EP claimed
EP-0250254-B1 CIS & TRANS STILBENES AND THEIR COMPOSITION FOR THE TREATMENT OF HYPERTENSION McNeilab, Inc. (US) 1991-06-19 EP disclosed
EP-0250254-A1 Cis & trans stilbenes and their composition for the treatment of hypertension McNeilab, Inc. (US) 1987-12-23 EP disclosed